Yoshiro Kato

Prof. Yoshiro Kato

Division of Diabetes, Department of Internal Medicine, Aichi Medical University School of Medicine

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 February 2015 in Journal of Diabetes Investigation
Verified
Journal Article
Open access
PDF file
THTomohide Hayami
Tomohide Hayami
YKYoshiro Kato
Yoshiro Kato
HKHideki Kamiya
Hideki Kamiya
MKMasaki Kondo
Masaki Kondo
ENEna Naito
Ena Naito
JNJiro Nakamura
Jiro Nakamura
We present a case of a 32‐year‐old diabetic woman with Prader–Willi syndrome who developed severe ketoacidosis caused by a sodium‐glucose cotransporter 2 (SGLT2) inhibitor, a novel class of antihyperglycemic agents, during a strict low‐carbohydrate diet. At admission, a serum glucose level of 191 mg/dL was relatively low, though laboratory evaluations showed severe ketoacidosis. This is the first report of ketoacidosis caused by a SGLT2 inhibitor. It is necessary to not only pay attention when using a SGLT2 inhibitor in patients following a low‐carbohydrate diet, but also to start a low‐carbohydrate diet in patients treated with a SGLT2 inhibitor because of a high risk for developing ketoacidosis.

1 October 2019 in Neuroscience Research
Verified
Journal Article
Closed access
AKAyako Kato
Ayako Kato
YTYasuaki Tatsumi
Yasuaki Tatsumi
HYHideji Yako
Hideji Yako
Kazunori SangoKazunori Sango
Kazunori Sango
THTatsuhito Himeno
Tatsuhito Himeno
Koichi KatoKoichi Kato
Koichi Kato

17 June 2010 in Hormone and Metabolic Research
Verified
Journal Article
Closed access
PDF file
YKYoshiro Kato
Yoshiro Kato
NKN. Koide
N. Koide
TKT. Komatsu
T. Komatsu
GTG. Tumurkhuu
G. Tumurkhuu
JDJ. Dagvadorj
J. Dagvadorj
TYT. Yokochi
T. Yokochi
Metformin is reported to ameliorate inflammation in diabetic patients. The effect of metformin on lipopolysaccharide-induced nitric oxide production was studied by using RAW 264.7 macrophage-like cells. The action of metformin was analyzed by dividing lipopolysaccharide signaling into the MyD88-dependent and -independent pathways. Metformin significantly reduced the expression of an inducible type of nitric oxide synthase and inhibited lipopolysaccharide-induced nitric oxide production. On the other hand, metformin did not inhibit lipopolysaccharide-induced tumor necrosis factor-α production. The expression levels of interferon-β protein and mRNA, which is a key molecule in MyD88-independent pathway, were significantly inhibited by metformin. Compound C, a specific AMP-activated protein kinase inhibitor, did not affect the inhibitory action of metformin. Metformin was suggested to inhibit lipopolysaccharide-induced nitric oxide production via inhibition of interferon-β production in MyD88-independent pathway. Metformin might exhibit an anti- inflammatory action on diabetic complications as well as the antidiabetic action.

15 February 2021 in Biomolecules
Verified
Journal Article
Open access
PDF file
Mohammad Sarif MohiuddinMohammad Sarif Mohiuddin
Mohammad Sarif Mohiuddin
THTatsuhito Himeno
Tatsuhito Himeno
YYYuichiro Yamada
Yuichiro Yamada
YMYoshiaki Morishita
Yoshiaki Morishita
MKMasaki Kondo
Masaki Kondo
HKHideki Kamiya
Hideki Kamiya
Although diabetic polyneuropathy (DPN) is a frequent diabetic complication, no effective therapeutic approach has been established. Glucagon is a crucial hormone for glucose homeostasis but has pleiotropic effects, including neuroprotective effects in the central nervous system. However, the importance of glucagon in the peripheral nervous system (PNS) has not been clarified. Here, we hypothesized that glucagon might have a neuroprotective function in the PNS. The immortalized rat dorsal root ganglion (DRG) neuronal cell line 50B11 was treated with methylglyoxal (MG) to mimic an in vitro DPN model. The cells were cultured with or without glucagon or MG. Neurotoxicity, survival, apoptosis, neurite projection, cyclic adenosine monophosphate (cAMP), and protein kinase A (PKA) were examined. Glucagon had no cytotoxicity and rescued the cells from neurotoxicity. Cell survival was increased by glucagon. The ratio of apoptotic cells, which was increased by MG, was reduced by glucagon. Neurite outgrowth was accelerated in glucagon-treated cells. Cyclic AMP and PKA accumulated in the cells after glucagon stimulation. In conclusion, glucagon protected the DRG neuronal cells from MG-induced cellular stress. The cAMP/PKA pathway may have significant roles in those protective effects of glucagon. Glucagon may be a potential target for the treatment of DPN.

23 April 2014 in Immunopharmacology and Immunotoxicology
Verified
Journal Article
Closed access
PDF file
YKYoshiro Kato
Yoshiro Kato
HKHideki Kamiya
Hideki Kamiya
NKNaoki Koide
Naoki Koide
EOErdenezaya Odkhuu
Erdenezaya Odkhuu
TKTakayuki Komatsu
Takayuki Komatsu
TYTakashi Yokochi
Takashi Yokochi
The effect of spironolactone (SPIR) on lipopolysaccharide (LPS)-induced production of proinflammatory mediators was examined using RAW 264.7 macrophage-like cells and mouse peritoneal macrophages. SPIR significantly inhibited LPS-induced production of nitric oxide (NO), tumor necrosis factor-α and prostaglandin E2. The inhibition was not mediated by cell death. SPIR reduced the expression of an inducible NO synthase mRNA in response to LPS. SPIR significantly inhibited phosphorylation of p65 nuclear factor (NF)-κB in response to LPS. Furthermore, SPIR inhibited phosphorylation of IκB kinase (IKK) as an upstream molecule of NF-κB in response to LPS. LPS did not induce the production of aldosterone in RAW 264.7 cells. Taken together, SPIR is suggested to inhibit LPS-induced proinflammatory mediators via inactivation of IKK/NF-κB in LPS signaling.

Verified
Journal Article
Open access
PDF file
YTYasuaki Tatsumi
Yasuaki Tatsumi
AKAyako Kato
Ayako Kato
NNNaoko NIIMI
Naoko NIIMI
HYHideji Yako
Hideji Yako
THTatsuhito Himeno
Tatsuhito Himeno
Koichi KatoKoichi Kato
Koichi Kato
Autophagy is the process by which intracellular components are degraded by lysosomes. It is also activated by oxidative stress; hence, autophagy is thought to be closely related to oxidative stress, one of the major causes of diabetic neuropathy. We previously reported that docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) induced antioxidant enzymes and protected Schwann cells from oxidative stress. However, the relationship between autophagy and oxidative stress-induced cell death in diabetic neuropathy has not been elucidated. Treatment with tert-butyl hydroperoxide (tBHP) decreased the cell survival rate, as measured by an MTT assay in immortalized Fischer rat Schwann cells 1 (IFRS1). A DHA pretreatment significantly prevented tBHP-induced cytotoxicity. tBHP increased autophagy, which was revealed by the ratio of the initiation markers, AMP-activated protein kinase, and UNC51-like kinase phosphorylation. Conversely, the DHA pretreatment suppressed excessive tBHP-induced autophagy signaling. Autophagosomes induced by tBHP in IFRS1 cells were decreased to control levels by the DHA pretreatment whereas autolysosomes were only partially decreased. These results suggest that DHA attenuated excessive autophagy induced by oxidative stress in Schwann cells and may be useful to prevent or reduce cell death in vitro. However, its potentiality to treat diabetic neuropathy must be validated in in vivo studies.